{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:14:50Z","timestamp":1793272490441,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s11102-023-01353-0","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T13:01:41Z","timestamp":1695301301000},"page":"653-659","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical and prognostic significance of granulation patterns in somatotroph adenomas\/tumors of the pituitary: a meta-analysis"],"prefix":"10.1007","volume":"26","author":[{"given":"Huy Gia","family":"Vuong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian F.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"issue":"3","key":"1353_CR1","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12022-017-9498-z","volume":"28","author":"O Mete","year":"2017","unstructured":"Mete O, Lopes MB (2017) Overview of the 2017 WHO classification of pituitary tumors. Endocr Pathol 28(3):228\u2013243","journal-title":"Endocr Pathol"},{"issue":"1","key":"1353_CR2","first-page":"20","volume":"33","author":"S Yamada","year":"1993","unstructured":"Yamada S, Aiba T, Sano T et al (1993) Growth hormone-producing pituitary adenomas: correlations between clinical characteristics and morphology. Neurosurgery 33(1):20\u201327","journal-title":"Neurosurgery"},{"issue":"2","key":"1353_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s12022-008-9029-z","volume":"19","author":"A Obari","year":"2008","unstructured":"Obari A, Sano T, Ohyama K et al (2008) Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form. Endocr Pathol 19(2):82\u201391","journal-title":"Endocr Pathol"},{"issue":"3","key":"1353_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1210\/edrv-4-3-271","volume":"4","author":"S Melmed","year":"1983","unstructured":"Melmed S, Braunstein GD, Horvath E, Ezrin C, Kovacs K (1983) Pathophysiology of acromegaly. Endocr Rev 4(3):271\u2013290","journal-title":"Endocr Rev"},{"issue":"4","key":"1353_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1530\/EJE-10-0586","volume":"163","author":"Y Bakhtiar","year":"2010","unstructured":"Bakhtiar Y, Hirano H, Arita K et al (2010) Relationship between cytokeratin staining patterns and clinico-pathological features in somatotropinomae. Eur J Endocrinol 163(4):531\u2013539","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"1353_CR6","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s11102-012-0445-1","volume":"16","author":"J Brzana","year":"2013","unstructured":"Brzana J, Yedinak CG, Gultekin SH, Delashaw JB, Fleseriu M (2013) Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience. Pituitary 16(4):490\u2013498","journal-title":"Pituitary"},{"issue":"3","key":"1353_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1507\/endocrj.EJ11-0177","volume":"59","author":"M Kato","year":"2012","unstructured":"Kato M, Inoshita N, Sugiyama T et al (2012) Differential expression of genes related to drug responsiveness between sparsely and densely granulated somatotroph adenomas. Endocr J 59(3):221\u2013228","journal-title":"Endocr J"},{"key":"1353_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/723432","volume":"2013","author":"R Mori","year":"2013","unstructured":"Mori R, Inoshita N, Takahashi-Fujigasaki J et al (2013) Clinicopathological features of growth hormone-producing pituitary adenomas in 242 acromegaly patients: classification according to hormone production and cytokeratin distribution. ISRN Endocrinol 2013:723432","journal-title":"ISRN Endocrinol"},{"issue":"4","key":"1353_CR9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1530\/EJE-12-0864","volume":"168","author":"S Larkin","year":"2013","unstructured":"Larkin S, Reddy R, Karavitaki N, Cudlip S, Wass J, Ansorge O (2013) Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas. Eur J Endocrinol 168(4):491\u2013499","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1353_CR10","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s11102-014-0578-5","volume":"18","author":"CC Lee","year":"2015","unstructured":"Lee CC, Vance ML, Lopes MB, Xu Z, Chen CJ, Sheehan J (2015) Stereotactic radiosurgery for acromegaly: outcomes by adenoma subtype. Pituitary 18(3):326\u2013334","journal-title":"Pituitary"},{"issue":"11","key":"1353_CR11","doi-asserted-by":"publisher","first-page":"6290","DOI":"10.1210\/jc.2005-0998","volume":"90","author":"S Bhayana","year":"2005","unstructured":"Bhayana S, Booth GL, Asa SL, Kovacs K, Ezzat S (2005) The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly. J Clin Endocrinol Metab 90(11):6290\u20136295","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1353_CR12","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1007\/s00701-014-2230-6","volume":"156","author":"S Sarkar","year":"2014","unstructured":"Sarkar S, Chacko AG, Chacko G (2014) An analysis of granulation patterns, MIB-1 proliferation indices and p53 expression in 101 patients with acromegaly. Acta Neurochir. 156(12):2221\u20132230 (discussion 2230)","journal-title":"Acta Neurochir."},{"issue":"1","key":"1353_CR13","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1365-2265.2011.04163.x","volume":"76","author":"SL Fougner","year":"2012","unstructured":"Fougner SL, Casar-Borota O, Heck A, Berg JP, Bollerslev J (2012) Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly. Clin Endocrinol 76(1):96\u2013102","journal-title":"Clin Endocrinol"},{"issue":"7","key":"1353_CR14","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1210\/jc.2009-2670","volume":"95","author":"A Giustina","year":"2010","unstructured":"Giustina A, Chanson P, Bronstein MD et al (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95(7):3141\u20133148","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1353_CR15","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539\u20131558","journal-title":"Stat Med"},{"key":"1353_CR16","doi-asserted-by":"crossref","unstructured":"Vuong HG, Dunn IF (2023) The clinicopathological features and prognosis of silent corticotroph tumors: an updated systematic review and meta-analysis. Endocrine","DOI":"10.1007\/s12020-023-03449-w"},{"issue":"1","key":"1353_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12902-021-00850-2","volume":"21","author":"M Dehghani","year":"2021","unstructured":"Dehghani M, Davoodi Z, Bidari F et al (2021) Association of different pathologic subtypes of growth hormone producing pituitary adenoma and remission in acromegaly patients: a retrospective cohort study. BMC Endocr Disord 21(1):186","journal-title":"BMC Endocr Disord"},{"key":"1353_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2022.101502","volume":"67","author":"ET Durmu\u015f","year":"2022","unstructured":"Durmu\u015f ET, Atmaca A, Kefeli M et al (2022) Age, GH\/IGF-1 levels, tumor volume, T2 hypointensity, and tumor subtype rather than proliferation and invasion are all reliable predictors of biochemical response to somatostatin analogue therapy in patients with acromegaly: a clinicopathological study. Growth Horm IGF Res 67:101502","journal-title":"Growth Horm IGF Res"},{"issue":"1","key":"1353_CR19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/cen.14465","volume":"95","author":"L Heng","year":"2021","unstructured":"Heng L, Liu X, Jia D et al (2021) Preoperative prediction of granulation pattern subtypes in GH-secreting pituitary adenomas. Clin Endocrinol 95(1):134\u2013142","journal-title":"Clin Endocrinol"},{"issue":"2","key":"1353_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1530\/EJE-15-0832","volume":"174","author":"D Iacovazzo","year":"2016","unstructured":"Iacovazzo D, Carlsen E, Lugli F et al (2016) Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. Eur J Endocrinol 174(2):241\u2013250","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1353_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1530\/EJE-13-0349","volume":"169","author":"L Kasuki","year":"2013","unstructured":"Kasuki L, Wildemberg LE, Neto LV, Marcondes J, Takiya CM, Gadelha MR (2013) Ki-67 is a predictor of acromegaly control with octreotide LAR independent of SSTR2 status and relates to cytokeratin pattern. Eur J Endocrinol 169(2):217\u2013223","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1353_CR22","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s11102-020-01077-5","volume":"23","author":"YW Park","year":"2020","unstructured":"Park YW, Kang Y, Ahn SS et al (2020) Radiomics model predicts granulation pattern in growth hormone-secreting pituitary adenomas. Pituitary 23(6):691\u2013700","journal-title":"Pituitary"},{"issue":"3","key":"1353_CR23","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/his.14366","volume":"79","author":"J Soukup","year":"2021","unstructured":"Soukup J, Cesak T, Hornychova H et al (2021) Cytokeratin 8\/18-negative somatotroph pituitary neuroendocrine tumours (PitNETs, adenomas) show variable morphological features and do not represent a clinicopathologically distinct entity. Histopathology 79(3):406\u2013415","journal-title":"Histopathology"},{"issue":"2","key":"1353_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s11102-020-01096-2","volume":"24","author":"AA Swanson","year":"2021","unstructured":"Swanson AA, Erickson D, Donegan DM et al (2021) Clinical, biological, radiological, and pathological comparison of sparsely and densely granulated somatotroph adenomas: a single center experience from a cohort of 131 patients with acromegaly. Pituitary 24(2):192\u2013206","journal-title":"Pituitary"},{"issue":"2","key":"1353_CR25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s12020-021-02767-1","volume":"74","author":"Y Tang","year":"2021","unstructured":"Tang Y, Xie T, Wu S et al (2021) Quantitative proteomics revealed the molecular characteristics of distinct types of granulated somatotroph adenomas. Endocrine 74(2):375\u2013386","journal-title":"Endocrine"},{"issue":"4","key":"1353_CR26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1530\/EJE-13-0134","volume":"169","author":"B Mayr","year":"2013","unstructured":"Mayr B, Buslei R, Theodoropoulou M, Stalla GK, Buchfelder M, Sch\u00f6fl C (2013) Molecular and functional properties of densely and sparsely granulated GH-producing pituitary adenomas. Eur J Endocrinol 169(4):391\u2013400","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1353_CR27","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","volume":"43","author":"S Melmed","year":"2022","unstructured":"Melmed S, Kaiser UB, Lopes MB et al (2022) Clinical biology of the pituitary adenoma. Endocr Rev 43(6):1003\u20131037","journal-title":"Endocr Rev"},{"issue":"24","key":"1353_CR28","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1056\/NEJMra062453","volume":"355","author":"S Melmed","year":"2006","unstructured":"Melmed S (2006) Medical progress: acromegaly. N Engl J Med 355(24):2558\u20132573","journal-title":"N Engl J Med"},{"issue":"4","key":"1353_CR29","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1210\/en.2002-220949","volume":"144","author":"T Florio","year":"2003","unstructured":"Florio T, Morini M, Villa V et al (2003) Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activities. Endocrinology 144(4):1574\u20131584","journal-title":"Endocrinology"},{"issue":"5","key":"1353_CR30","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.tem.2012.11.007","volume":"24","author":"MR Gadelha","year":"2013","unstructured":"Gadelha MR, Kasuki L, Korbonits M (2013) Novel pathway for somatostatin analogs in patients with acromegaly. Trends Endocrinol Metab 24(5):238\u2013246","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"1353_CR31","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00018-009-0240-y","volume":"67","author":"J C\u00f3rdoba-Chac\u00f3n","year":"2010","unstructured":"C\u00f3rdoba-Chac\u00f3n J, Gahete MD, Duran-Prado M et al (2010) Identification and characterization of new functional truncated variants of somatostatin receptor subtype 5 in rodents. Cell Mol Life Sci 67(7):1147\u20131163","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"1353_CR32","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1210\/jc.2008-2564","volume":"94","author":"M Dur\u00e1n-Prado","year":"2009","unstructured":"Dur\u00e1n-Prado M, Gahete MD, Mart\u00ednez-Fuentes AJ et al (2009) Identification and characterization of two novel truncated but functional isoforms of the somatostatin receptor subtype 5 differentially present in pituitary tumors. J Clin Endocrinol Metab 94(7):2634\u20132643","journal-title":"J Clin Endocrinol Metab"},{"key":"1353_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000079041","volume":"32","author":"T Sano","year":"2004","unstructured":"Sano T, Rong QZ, Kagawa N, Yamada S (2004) Down-regulation of E-cadherin and catenins in human pituitary growth hormone-producing adenomas. Front Horm Res 32:127\u2013132","journal-title":"Front Horm Res"},{"issue":"12","key":"1353_CR34","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/modpathol.3800965","volume":"20","author":"ZR Qian","year":"2007","unstructured":"Qian ZR, Sano T, Yoshimoto K et al (2007) Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas. Mod Pathol 20(12):1269\u20131277","journal-title":"Mod Pathol"},{"issue":"6","key":"1353_CR35","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1210\/jcem-71-6-1421","volume":"71","author":"A Spada","year":"1990","unstructured":"Spada A, Arosio M, Bochicchio D et al (1990) Clinical, biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase. J Clin Endocrinol Metab 71(6):1421\u20131426","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1353_CR36","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s11102-015-0662-5","volume":"18","author":"ZA Efstathiadou","year":"2015","unstructured":"Efstathiadou ZA, Bargiota A, Chrisoulidou A et al (2015) Impact of gsp mutations in somatotroph pituitary adenomas on growth hormone response to somatostatin analogs: a meta-analysis. Pituitary 18(6):861\u2013867","journal-title":"Pituitary"},{"issue":"6","key":"1353_CR37","first-page":"861","volume":"20","author":"PR Mazal","year":"2001","unstructured":"Mazal PR, Czech T, Sedivy R et al (2001) Prognostic relevance of intracytoplasmic cytokeratin pattern, hormone expression profile, and cell proliferation in pituitary adenomas of akromegalic patients. Clin Neuropathol 20(4):163-171","journal-title":"Clin Neuropathol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-023-01353-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-023-01353-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-023-01353-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T23:50:16Z","timestamp":1700697016000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-023-01353-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1353"],"URL":"https:\/\/doi.org\/10.1007\/s11102-023-01353-0","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,21]]},"assertion":[{"value":"28 August 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}